XEN445 is a potent and selective endothelial lipase inhibitor with an IC50 of 0.237 µM. It demonstrates favorable pharmacokinetic and ADME profiles, making it a useful chemical probe for researching lipid metabolism and cardiovascular diseases in both in vitro and in vivo models.